Table 4 Pattern of lung involvement in CVID patients (n = 29) with and without ILD
Parameters | Total (n = 29)** | With ILD (n = 9) | Without ILD (n = 20) | p-value# |
|---|---|---|---|---|
Infiltration (n = 29) (%) | 2 (6.9) | 0 (0) | 2 (10) | 0.326 |
Hilar lymphadenopathy (n = 29) (%) | 1 (3.4) | 0 (0) | 1 (5) | 0.495 |
Hyperinflation (n = 29) (%) | 7 (24.1) | 0 (0) | 7 (35) | 0.040* |
Atelectasis (n = 29) (%) | 7 (24.1) | 1 (11.1) | 6 (30) | 0.271 |
Nodule (n = 29) (%) | 8 (27.6) | 4 (44.4) | 4 (20) | 0.173 |
Fibrotic bond (n = 29) (%) | 6 (20.7) | 3 (33.3) | 3 (15) | 0.260 |
Consolidation (n = 29) (%) | 7 (24.1) | 4 (44.4) | 3 (15) | 0.086 |
Ground-glass opacity (n = 29) (%) | 6 (20.7) | 3 (33.3) | 3 (15) | 0.260 |
Interseptal Pleural thickening (n = 29) (%) | 2 (6.9) | 1 (11.1) | 1 (5) | 0.548 |
Peribronchial wall thickening (n = 29) (%) | 8 (27.6) | 1 (11.1) | 7 (35) | 0.183 |
Mosaic attenuation pattern (n = 29) (%) | 3 (10.3) | 1 (11.1) | 2 (10) | 0.928 |